Evidence map›Paper›PMID 24060923›Full record

ReviewAdvanced drug delivery reviews2014

Multifunctional nanoparticles for brain tumor imaging and therapy.

Yu Cheng, Ramin A Morshed, Brenda Auffinger, Alex L Tobias, Maciej S Lesniak

Open access · greenAbstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 344 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Advancements in nanotheranostics for glioma therapy.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Engineering metabolism to modulate immunity.Advanced drug delivery reviews · 2024
    Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yu ChengThe Brain Tumor Center, The University of Chicago, Chicago, IL, USA.
Ramin A MorshedThe Brain Tumor Center, The University of Chicago, Chicago, IL, USA.
Brenda AuffingerThe Brain Tumor Center, The University of Chicago, Chicago, IL, USA.
Alex L TobiasThe Brain Tumor Center, The University of Chicago, Chicago, IL, USA.
Maciej S LesniakThe Brain Tumor Center, The University of Chicago, Chicago, IL, USA. Electronic address: mlesniak@surgery.bsd.uchicago.edu.
University of Chicago · US

Funding

Magnetic-vortex microdiscs for glioma therapyR01NS077388 · NINDS · UNIVERSITY OF CHICAGO · PI LESNIAK, MACIEJ S · 2012 to 2015
$2.5M
NINDS NIH HHS R01 NS077388
6 · The paper itself

Abstract

Brain tumors are a diverse group of neoplasms that often carry a poor prognosis for patients. Despite tremendous efforts to develop diagnostic tools and therapeutic avenues, the treatment of brain tumors remains a formidable challenge in the field of neuro-oncology. Physiological barriers including the blood-brain barrier result in insufficient accumulation of therapeutic agents at the site of a tumor, preventing adequate destruction of malignant cells. Furthermore, there is a need for improvements in brain tumor imaging to allow for better characterization and delineation of tumors, visualization of malignant tissue during surgery, and tracking of response to chemotherapy and radiotherapy. Multifunctional nanoparticles offer the potential to improve upon many of these issues and may lead to breakthroughs in brain tumor management. In this review, we discuss the diagnostic and therapeutic applications of nanoparticles for brain tumors with an emphasis on innovative approaches in tumor targeting, tumor imaging, and therapeutic agent delivery. Clinically feasible nanoparticle administration strategies for brain tumor patients are also examined. Furthermore, we address the barriers towards clinical implementation of multifunctional nanoparticles in the context of brain tumor management.

Indexed as

AnimalsAntineoplastic AgentsBrain NeoplasmsContrast MediaDiagnostic ImagingHumansNanoparticlesAntineoplastic AgentsContrast MediaBrain tumorDiagnosisDrug deliveryImagingNanoparticlesNanotechnologyTheranosticsTherapy

Identifiers

PMID24060923
PMCPMC3948347
OpenAlexW1990641613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.